Search
for
Sort by
Research 91–120 of 120
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Transitional Changes in Fatigue-Related Symptoms Due to Long COVID: A Single-Center Retrospective Observational Study in Japan
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- Hair growth-promotion effects at the cellular level and antioxidant activity of the plant-based extract Phyllotex™
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Persistence of Long-COVID symptoms in a heterogenous prospective cohort
- Covid induced telogen effluvium (CITE): An insight
- Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- A Review of the Characteristics of Clinical Trials and Potential Medications for Alcohol Dependence: Data Analysis from ClinicalTrials.gov
- Recent Advances in the Electro-Active Therapeutic Phytochemical-Based Sensors
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Italian National Registry of Alopecia Areata: an epidemiological study of 699 Italian patients
- 5-Alpha Reductase Inhibitor Use and Prostate Cancer Prevention: A Victim of the Times?
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Hormonal Therapies for Alopecia
- Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database
- Peculiarities of long-COVID-19 and treatment strategy: a clinical case
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia